Journal
BIOMEDICINE & PHARMACOTHERAPY
Volume 138, Issue -, Pages -Publisher
ELSEVIER FRANCE-EDITIONS SCIENTIFIQUES MEDICALES ELSEVIER
DOI: 10.1016/j.biopha.2021.111518
Keywords
SARS-CoV-2; COVID-19; Antiviral therapy Immunotherapy; Cell therapy; Nanomedicine; Antivirals
Funding
- national COVID-19 committee of the National Institute of Genetic Engineering and Biotechnology (NIGEB) , Tehran, Iran
Ask authors/readers for more resources
Various treatment strategies have been explored for COVID-19, including vaccines, antiviral drugs, immunotherapy, etc. Each treatment method has its own advantages and disadvantages, which need to be carefully considered in the treatment of COVID-19.
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) emerged in Wuhan, China, in December 2020 and coronavirus disease 19 (COVID-19) was later announced as pandemic by the World Health Organization (WHO). Since then, several studies have been conducted on the prevention and treatment of COVID-19 by potential vaccines and drugs. Although, the governments and global population have been attracted by some vaccine production projects, the presence of SARS-CoV-2-specific antiviral drugs would be an urge necessity in parallel with the efficient preventive vaccines. Various nonspecific drugs produced previously against other bacterial, viral, and parasite infections were recently evaluated for treating patients with COVID-19. In addition to therapeutic properties of these anti-COVID-19 compounds, some adverse effects were observed in different human organs as well. Not only several attentions were paid to antiviral therapy and treatment of COVID-19, but also nanomedicine, immunotherapy, and cell therapy were conducted against this viral infection. In this review study, we planned to introduce the present and potential future treatment strategies against COVID-19 and define the advantages and disadvantages of each treatment strategy.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available